Related Experiment Video
Updated: Apr 25, 2026

Expression of Recombinant Proteins in the Methylotrophic Yeast Pichia pastoris
Published on: February 25, 2010
Multi-gene metabolic engineering of Pichia pastoris to synthesize ectoine
Shuai Zhang1, Bingjie Cheng2, Qing Liao2
1State Key Laboratory of Food Science and Resources, Jiangnan University, 1800 Lihu Ave., Wuxi 214122, China; School of Biotechnology, Jiangnan University, 1800 Lihu Ave., Wuxi 214122, China; Guangzhou Cn-Ferment Biotechnology Co., Ltd., Guangzhou 510550, China.
Abstract:
As a promising osmolyte, ectoine has been widely applied in cosmetics, food, and pharmaceutical industries in recent years, therefore its biomanufacturer has attracted increasing interest. Ectoine-producing isolates were previously screened from halophilic microorganisms. After ectoine synthetase was identified, genetic engineering of Escherichia coli, Corynebacterium glutamicum, and Hansenula polymorpha were employed to produce ectoine. However, Pichia pastoris, another successful host capable of high-density cell culture, had not yet been exploited as an ectoine-synthesizing host. In this study, therefore, P. pastoris was employed for the first time to produce ectoine through multi-gene metabolic engineering. Firstly, Chromohalobacter salexigens HZS/E, a halophilic isolate producing 46.96 mg/mL ectoine, was identified, while ectABC encoding ectoine synthetase was cloned. Later, ectABC was introduced into P. pastoris GS115 under the control of two different promoters. The results showed that PGAP-based HZS02 accumulated 8.03 g/L, 12.62 % higher than 7.13 g/L produced by PAOX-based HZS01. Finally, to enhance the supply of the precursor l-aspartate-β-semialdehyde, three genes (aspC, aK, and asD) were individually and collectively overexpressed. The highest ectoine yield was achieved at 10.88 g/L by GS115/pGAPZ A-ectABC-aspC-aK-asD. This study demonstrated that P. pastoris was a highly effective host for ectoine biosynthesis.
Related Concept Videos
Other Glycolytic Pathways
Bioreactor Controls-III
Production of Pharmaceuticals

